BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luciani P, Fibbi B, Mazzanti B, Deledda C, Ballerini L, Aldinucci A, Benvenuti S, Saccardi R, Peri A. The effects of Exendin-4 on bone marrow-derived mesenchymal cells. Endocrine 2018;60:423-34. [PMID: 29094257 DOI: 10.1007/s12020-017-1430-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Habib SA, Kamal MM, El-Maraghy SA, Senousy MA. Exendin-4 enhances osteogenic differentiation of adipose tissue mesenchymal stem cells through the receptor activator of nuclear factor-kappa B and osteoprotegerin signaling pathway. J Cell Biochem 2022. [PMID: 35338509 DOI: 10.1002/jcb.30236] [Reference Citation Analysis]
2 Grammatiki M, Antonopoulou V, Kotsa K. Emerging incretin hormones actions: focus on bone metabolism. Minerva Endocrinol 2019;44. [DOI: 10.23736/s0391-1977.19.03008-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tencerova M, Okla M, Kassem M. Insulin Signaling in Bone Marrow Adipocytes. Curr Osteoporos Rep 2019;17:446-54. [PMID: 31749085 DOI: 10.1007/s11914-019-00552-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
4 Kang W, Du L, Liang Q, Zhang R, Lv C, Ge S. Transcriptome analysis reveals the mechanism of stromal cell-derived factor-1 and exendin-4 synergistically promoted periodontal ligament stem cells osteogenic differentiation. PeerJ 2021;9:e12091. [PMID: 34532163 DOI: 10.7717/peerj.12091] [Reference Citation Analysis]
5 Liang Q, Du L, Zhang R, Kang W, Ge S. Stromal cell-derived factor-1/Exendin-4 cotherapy facilitates the proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo. Cell Prolif 2021;54:e12997. [PMID: 33511708 DOI: 10.1111/cpr.12997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Santopaolo M, Gu Y, Spinetti G, Madeddu P. Bone marrow fat: friend or foe in people with diabetes mellitus? Clin Sci (Lond) 2020;134:1031-48. [PMID: 32337536 DOI: 10.1042/CS20200220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Mansur SA, Mieczkowska A, Flatt PR, Chappard D, Irwin N, Mabilleau G. The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice. Front Endocrinol (Lausanne) 2019;10:51. [PMID: 30809192 DOI: 10.3389/fendo.2019.00051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]